VF
LIMN

Virtu Financial’s Liminatus Pharma LIMN Stock Holding History

Virtu Financial’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Buy
+27,468
New +$14.6K ﹤0.01% 1513

Other funds holding LIMN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's LIMN Position: Q1 2026 in Review

Virtu Financial opened a new position in Liminatus Pharma (LIMN) in Q1 2026: 27,468 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1513 among its holdings.

15 funds tracked by Wall St. Rank hold LIMN as of Q1 2026.

  • Virtu Financial held 27,468 shares of Liminatus Pharma worth $5K as of Q1 2026.
  • Liminatus Pharma was a new Virtu Financial position in Q1 2026.
  • Liminatus Pharma made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1513 holding.
  • 15 funds tracked by Wall St. Rank held Liminatus Pharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.